
    
      The primary objective of this study is to determine the ability of a serum S-100B to predict
      traumatic abnormalities on brain CT scan after mild traumatic brain injury (mild TBI). The
      secondary objective is to determine the relationship between initial S-100B levels and
      cognitive outcome at one month.
    
  